Ranking · Unmet Need
Research Gap Index
Burden percentile minus research-activity percentile (publications, last 5 years) within the same scope. Positive values flag cancers with high mortality burden but comparatively little literature. Caveat (Phase 1): literature counts are query-based per entity (query stored on each row); they are not aggregated over descendants.
Computedci-research-gap-v1unit: percentile pointshigher = worseAll metrics
| Rank | Δ | Cancer | Research Gap Index (percentile points) | Percentile | Confidence | Sources | Why #n? |
|---|---|---|---|---|---|---|---|
| 1 | = | Malignant Central Nervous System Neoplasm | +70 | 100 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608898 |
| 2 | = | Malignant Uterine Corpus Neoplasm | +43.3 | 96.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608899 |
| 3 | = | Malignant Kidney Neoplasm | +20 | 93.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608901 |
| 3 | ▲1 | Malignant Pancreatic Neoplasm | +20 | 93.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608900 |
| 5 | = | Malignant Colon Neoplasm | +16.7 | 86.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608902 |
| 6 | = | Malignant Liver Neoplasm | +16.6 | 83.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608903 |
| 7 | = | Malignant Esophageal Neoplasm | +13.4 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608904 |
| 7 | = | Non-Hodgkin Lymphoma | +13.4 | 80 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608905 |
| 9 | = | Malignant Salivary Gland Neoplasm | +10 | 73.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608906 |
| 10 | = | Malignant Vulvar Neoplasm | +6.6 | 70 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608907 |
| 11 | = | Malignant Laryngeal Neoplasm | +3.4 | 66.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608908 |
| 12 | = | Malignant Lung Neoplasm | +3.3 | 63.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608909 |
| 12 | ▲5 | Malignant Rectal Neoplasm | +3.3 | 63.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608911 |
| 12 | ▲1 | Multiple Myeloma | +3.3 | 63.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608910 |
| 15 | ▼2 | Cutaneous Melanoma | 0 | 53.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608912 |
| 15 | ▲3 | Malignant Anal Neoplasm | 0 | 53.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608914 |
| 15 | ▲3 | Malignant Bladder Neoplasm | 0 | 53.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608913 |
| 18 | = | Malignant Hypopharyngeal Neoplasm | -3.3 | 43.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608915 |
| 19 | ▼1 | Malignant Vaginal Neoplasm | -3.4 | 40 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608916 |
| 20 | ▲5 | Malignant Prostate Neoplasm | -6.6 | 36.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608917 |
| 21 | ▲3 | Malignant Nasopharyngeal Neoplasm | -6.7 | 33.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608918 |
| 22 | = | Leukemia | -6.7 | 30 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608919 |
| 22 | ▲3 | Malignant Breast Neoplasm | -6.7 | 30 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608920 |
| 22 | ▲1 | Malignant Mesothelioma | -6.7 | 30 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608921 |
| 25 | ▲8 | Malignant Ovarian Neoplasm | -23.3 | 20 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608922 |
| 26 | ▲4 | Hodgkin Lymphoma | -23.3 | 16.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608923 |
| 26 | ▲4 | Malignant Penile Neoplasm | -23.3 | 16.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608924 |
| 26 | ▲4 | Malignant Testicular Neoplasm | -23.3 | 16.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608925 |
| 29 | ▲5 | Malignant Thyroid Gland Neoplasm | -26.7 | 6.7 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608926 |
| 30 | ▲4 | Malignant Gastric Neoplasm | -40 | 3.3 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608927 |
| 31 | ▲5 | Malignant Cervical Neoplasm | -43.3 | 0 | Medium confidence | cdc-uscspubmedcdc-wonderseeriarc-globocan | inputs
ranking row 2608928 |
Data updated 16 hours agoSource updated unknown31 eligible entities · inputs hash 223409ea4719a317e41b9bc7